The Securities and Exchange Commission staff has issued fresh guidance on its marketing rule, giving RIAs more clarity around using testimonials from certain disciplined individuals and more ...

New rules to let state-registered investment advisors publish testimonials and online reviews from their clients have been proposed by the North American Securities Administrators Association (NASAA), ...

Imagine if you could bottle the enthusiasm your clients have for working with you and use it to capture new business. That’s where real estate testimonials come into play. We all know that getting ...

Ah, tried and true testimonial spots. Some work well, some… not so much. Audiences have heard so many commercials using testimonials that yours better ring true, or your advertisers’ messages will be ...

Finalized last year, the U.S. Federal Trade Commission’s (FTC) Final Rule on the Use of Consumer Reviews and Testimonials (the “Final Rule”) principally addresses the sale, purchase, and publication ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

One of the reasons we hear from financial advisors who hesitate or don’t participate in testimonial marketing is the fear of exposing their clients’ information, and especially concerns that clients ...

Instagram is introducing a new way for creators to work with brands to make money by recommending products. On Thursday, Meta introduced an addition to its Partnership Ads called Testimonials, which ...

It's hard to believe, given the anticipation and discussion that preceded it, but the SEC's revised marketing rule went into effect more than three and a half years ago. And while it's understandable ...

Dentists, doctors, professors, dry cleaners. Everybody is asking for a rating these days. By Eric A. Taub In the 1980s, Ed Koch, then New York’s mayor, often grabbed bemused commuters emerging from ...

In the wake of a market pull in obesity nearly five years ago, the other shoe has dropped for Eisai’s serotonin 2C receptor agonist lorcaserin. Eisai has formally terminated a phase 3 study of ...